🚀 VC round data is live in beta, check it out!
CryoPort Valuation Multiples
Discover revenue and EBITDA valuation multiples for CryoPort and similar public comparables like Absci, Avacta Group, Genomictree, Pacific Biosciences and more.
CryoPort Overview
About CryoPort
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Founded
1990
HQ
Employees
1.2K
Website
Sectors
Financials (LTM)
EV
$260M
CryoPort Financials
CryoPort reported last 12-month revenue of $180M and negative EBITDA of ($4M).
In the same LTM period, CryoPort generated $85M in gross profit, ($4M) in EBITDA losses, and had net loss of ($34M).
Revenue (LTM)
CryoPort P&L
In the most recent fiscal year, CryoPort reported revenue of $176M and EBITDA of ($2M).
CryoPort expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $180M | XXX | $176M | XXX | XXX | XXX |
| Gross Profit | $85M | XXX | $83M | XXX | XXX | XXX |
| Gross Margin | 47% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | ($4M) | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (1%) | XXX | XXX | XXX |
| EBIT Margin | (22%) | XXX | (21%) | XXX | XXX | XXX |
| Net Profit | ($34M) | XXX | $78M | XXX | XXX | XXX |
| Net Margin | (19%) | XXX | 44% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
CryoPort Stock Performance
CryoPort has current market cap of $411M, and enterprise value of $260M.
Market Cap Evolution
CryoPort's stock price is $8.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $260M | $411M | 0.0% | XXX | XXX | XXX | $1.56 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCryoPort Valuation Multiples
CryoPort trades at 1.4x EV/Revenue multiple, and (59.0x) EV/EBITDA.
EV / Revenue (LTM)
CryoPort Financial Valuation Multiples
As of March 31, 2026, CryoPort has market cap of $411M and EV of $260M.
Equity research analysts estimate CryoPort's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CryoPort has a P/E ratio of (11.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $411M | XXX | $411M | XXX | XXX | XXX |
| EV (current) | $260M | XXX | $260M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | (59.0x) | XXX | (124.2x) | XXX | XXX | XXX |
| EV/EBIT | (6.6x) | XXX | (7.1x) | XXX | XXX | XXX |
| EV/Gross Profit | 3.1x | XXX | 3.1x | XXX | XXX | XXX |
| P/E | (11.9x) | XXX | 5.2x | XXX | XXX | XXX |
| EV/FCF | (13.3x) | XXX | (12.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CryoPort Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
CryoPort Margins & Growth Rates
CryoPort's revenue in the last 12 month grew by 9%.
CryoPort's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
CryoPort's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CryoPort's rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
CryoPort Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Growth | (149%) | XXX | (105%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 9% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 68% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
CryoPort Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Absci | XXX | XXX | XXX | XXX | XXX | XXX |
| Avacta Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomictree | XXX | XXX | XXX | XXX | XXX | XXX |
| Pacific Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Nautilus Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CryoPort M&A Activity
CryoPort acquired XXX companies to date.
Last acquisition by CryoPort was on XXXXXXXX, XXXXX. CryoPort acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by CryoPort
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCryoPort Investment Activity
CryoPort invested in XXX companies to date.
CryoPort made its latest investment on XXXXXXXX, XXXXX. CryoPort invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by CryoPort
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CryoPort
| When was CryoPort founded? | CryoPort was founded in 1990. |
| Where is CryoPort headquartered? | CryoPort is headquartered in United States. |
| How many employees does CryoPort have? | As of today, CryoPort has over 1K employees. |
| Who is the CEO of CryoPort? | CryoPort's CEO is Jerrell W. Shelton. |
| Is CryoPort publicly listed? | Yes, CryoPort is a public company listed on Nasdaq. |
| What is the stock symbol of CryoPort? | CryoPort trades under CYRX ticker. |
| When did CryoPort go public? | CryoPort went public in 1993. |
| Who are competitors of CryoPort? | CryoPort main competitors are Absci, Avacta Group, Genomictree, Pacific Biosciences. |
| What is the current market cap of CryoPort? | CryoPort's current market cap is $411M. |
| What is the current revenue of CryoPort? | CryoPort's last 12 months revenue is $180M. |
| What is the current revenue growth of CryoPort? | CryoPort revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of CryoPort? | Current revenue multiple of CryoPort is 1.4x. |
| Is CryoPort profitable? | No, CryoPort is not profitable. |
| What is the current EBITDA of CryoPort? | CryoPort has negative EBITDA and is not profitable. |
| What is CryoPort's EBITDA margin? | CryoPort's last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of CryoPort? | Current EBITDA multiple of CryoPort is (59.0x). |
| What is the current FCF of CryoPort? | CryoPort's last 12 months FCF is ($20M). |
| What is CryoPort's FCF margin? | CryoPort's last 12 months FCF margin is (11%). |
| What is the current EV/FCF multiple of CryoPort? | Current FCF multiple of CryoPort is (13.3x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.